[TOP STORY] Will debt-laden Ascendis have to sell its crown jewel?

Loading player...
‘Blantyre and L1 Health have just added to the cocktail of what Ascendis could potentially become in the next 12 to 18 months’: Small-cap analyst Anthony Clarke.
26 Jan 2021 2AM English South Africa Business News · Business

Other recent episodes

Nvidia: What now?

A look at Nvidia and which South African consumer stocks could benefit from a recovery in discretionary spending. Plus, what upcoming credit rating reviews could mean for SA’s markets.
13 Nov 12AM 22 min